March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Recovery of ERG Components in the Cngb1-/- Model of RP Following Gene Therapy
Author Affiliations & Notes
  • Vithiyanjali Sothilingam
    Division of Ocular Degeneration, Ctr for Ophthal Inst for Ophthalmic Research, Tuebingen, Germany
  • Naoyuki Tanimoto
    Division of Ocular Degeneration, Ctr for Ophthal Inst for Ophthalmic Research, Tuebingen, Germany
  • Marina Garcia Garrido
    Division of Ocular Degeneration, Ctr for Ophthal Inst for Ophthalmic Research, Tuebingen, Germany
  • Regine Muehlfriedel
    Division of Ocular Degeneration, Ctr for Ophthal Inst for Ophthalmic Research, Tuebingen, Germany
  • Susanne Koch
    Pharmacy-Pharmacology, Ludwig-Maximilians-University Munich, Munich, Germany
  • Martin Biel
    Pharmacy-Pharmacology, Ludwig-Maximilians-University Munich, Munich, Germany
  • Stylianos Michalakis
    Pharmacy-Pharmacology, Ludwig-Maximilians-University Munich, Munich, Germany
  • Mathias W. Seeliger
    Division of Ocular Degeneration, Ctr for Ophthal Inst for Ophthalmic Research, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  Vithiyanjali Sothilingam, None; Naoyuki Tanimoto, None; Marina Garcia Garrido, None; Regine Muehlfriedel, None; Susanne Koch, None; Martin Biel, None; Stylianos Michalakis, None; Mathias W. Seeliger, None
  • Footnotes
    Support  DFG Se837/5-2 (KFO 134), Se837/6-2, Se837/7-1 (KFO 134), EU HEALTH-F2-2008-200234
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1911. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vithiyanjali Sothilingam, Naoyuki Tanimoto, Marina Garcia Garrido, Regine Muehlfriedel, Susanne Koch, Martin Biel, Stylianos Michalakis, Mathias W. Seeliger; Recovery of ERG Components in the Cngb1-/- Model of RP Following Gene Therapy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1911.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The lack of the CNG channel subunit CNGB1 leads to a loss of light-mediated electrical activity of rod photoreceptors and eventually to retinitis pigmentosa (RP). In the respective Cngb1-/- mouse model, visual function and retinal morphology could be restored using rAAV-mediated gene replacement therapy. Here we assess contributions of photoreceptor populations with different functional status (i.e. from treated and untreated regions within the same eye) on the sum responses of the Ganzfeld electroretinogram (ERG).

Methods: : Cngb1-/- knock-out mice were treated via subretinal injection of rAAV vector expressing murine CNGB1 under control of a rhodopsin promoter. Animals were injected at two weeks postnatally (PW2), and examined functionally and morphologically at PW10. ERGs were recorded under both scotopic and photopic conditions using a Jaeger/Toennies Multiliner Vision and a Roland Consult Ganzfeld system. In vivo retinal morphology was examined with optical coherence tomography (OCT, HE Spectralis™), and animals subsequently underwent histological analysis.

Results: : Cngb1-/- knock-out mice feature a small rod response even in the absence of the CNGB1 subunit (Huettl et al., J Neurosci 2005). The respective ERG component present in both treated and untreated eyes is in agreement with the hypothesis that homomeric CNG channels, composed of the CNGA1 subunit only, reach the outer segment membrane in a very small number. In treated eyes, we found an additional signal component from a proportion of rods responding with practically regular timing and sensitivity, which we attribute to the rescue area. Since the treated region in this study amounts to approximately 1/3-1/4 of the retina, signals were much smaller than normal rod ERGs. This difference was also reflected in the mixed rod and cone ERG responses.Although the rod ERG was strongly reduced, the morphological appearance of the retina was not much altered. The major difference in the OCT was a preservation of outer segment markers (OLM and IS/OS border) in treated eyes of Cngb1-/- mice.

Conclusions: : Here we show that gene replacement therapy in Cngb1-/- mice results in photoreceptor populations with different functional status. The respective ERG components will be of high diagnostic importance and may serve as endpoints in treatment trials.

Keywords: electroretinography: non-clinical • gene transfer/gene therapy • imaging/image analysis: non-clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×